Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CMPX will decline by -9.58% over the next 2 Weeks and hit $1.73 by Friday, August 14, 2026. In that time frame, CMPX's share price is expected to range between $1.66 and $1.80.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Aug 14, 2026 | 1.66 | 1.73 | 1.80 |
| Aug 13, 2026 | 1.69 | 1.75 | 1.82 |
| Aug 12, 2026 | 1.67 | 1.73 | 1.80 |
| Aug 11, 2026 | 1.70 | 1.77 | 1.84 |
| Aug 10, 2026 | 1.73 | 1.80 | 1.86 |
| Aug 7, 2026 | 1.76 | 1.82 | 1.89 |
| Aug 6, 2026 | 1.78 | 1.85 | 1.91 |
| Aug 5, 2026 | 1.76 | 1.83 | 1.89 |
| Aug 4, 2026 | 1.80 | 1.86 | 1.93 |
| Aug 3, 2026 | 1.83 | 1.89 | 1.95 |
CMPX shares fell -1.55% in Friday, July 31, 2026's trading session, dropping from a previous close of $1.94 to move at $1.91. The stock demonstrated notable intraday movement (see CMPX's key stats for a full breakdown), fluctuating between $1.86 and $1.96, a +5.24% trading range. While recent weeks have seen some volatility, CMPX has managed to secure a -5.45% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 2.64M shares changing hands, 728.89K more than the previous session. This amounted to $5.04M in total market activity.
Will CMPX Continue Its Downward Trend?
According to analyst ratings and projections for CMPX, Compass Therapeutics, Inc. shares are anticipated to decrease by -6.35%, potentially reaching $1.80 per share by August 14, 2026. Short-term technical indicators currently suggest a neutral sentiment for CMPX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 13 positive trading days within the past 30 sessions. Based on the CMPX stock forecast, now is not the best time to buy CMPX stock because its current trading price is +10.59% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on CMPX covering social and institutional perspectives.
CMPX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CMPX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 29.38% to 37.47%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 39.89%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 43.69%, maintains a neutral outlook for the long term. Insights into CMPX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Compass Therapeutics Short-Term Forecasts
CMPX Forecast For Next 5 Days
Our algorithm anticipates Compass Therapeutics (CMPX) stock could hit $2.03 by Aug 07, 2026. This represents a +6.35% rise from today's price, following a +9.60% change over the past five days.
CMPX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Compass Therapeutics, Inc. (CMPX) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $1.96, which would mean a +2.62% increase from the current price of $1.91. Projections for this period range from a high of $2.27 to a low of $1.71.
CMPX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Compass Therapeutics's price over the next three months point to a rise. CMPX stock is expected to peak at $8.79 on Sep 10, 2026 before potentially dipping to $5.52 on Oct 30, 2026. On average, CMPX is likely to trade around $7.52 in the coming 90 days.
Compass Therapeutics Stock Forecast 2025
Based on our predictive models, Compass Therapeutics (CMPX) is expected to trade between $3.91 and $8.79 throughout 2026. This would result in an average price of $6.63, potentially offering investors a +247.12% return from current levels.
Compass Therapeutics, Inc. Monthly Forecast 2026–2027
August 2026
According to our latest forecast models, Compass Therapeutics, Inc. (CMPX) is positioned to show a strong performance in August 2026. The price is predicted to move between $7.29 and $8.28, settling at an average of $7.65. This could translate to a +300.52% gain.
September 2026
Based on current market signals, Compass Therapeutics, Inc. is projected to trend september 2026. We forecast a trading range from $6.72 to $8.79, with a likely average price of $8.03. Investors could expect a potential return of +320.42%.
October 2026
Our predictive algorithms indicate Compass Therapeutics, Inc. stock may see a shift in October 2026. The expected range spans $5.52–$7.55, with an average target of $6.87. This represents a positive outlook and a possible gain of +259.69%.
November 2026
Analyzing established trends, Compass Therapeutics, Inc. looks set to move in November 2026. Projections place the stock between $5.06 and $6.10, averaging around $5.57. This suggests a +191.62% gain from current levels.
December 2026
Market indicators suggest Compass Therapeutics, Inc. could experience notable changes during December 2026. Prices could fluctuate within $3.91 to $5.91, with a midpoint forecast of $5.07. The stock might deliver a +165.45% gain.
January 2027
Forecasting for January 2027, models estimate that Compass Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $4.03 and $6.38, averaging $5.41. This signals a positive trajectory with potential returns around +183.25%.
February 2027
According to our latest forecast models, Compass Therapeutics, Inc. (CMPX) is positioned to show a strong performance in February 2027. The price is predicted to move between $3.64 and $6.58, settling at an average of $6.01. This could translate to a +214.66% gain.
March 2027
Based on current market signals, Compass Therapeutics, Inc. is projected to trend march 2027. We forecast a trading range from $2.00 to $5.25, with a likely average price of $4.51. Investors could expect a potential return of +136.13%.
April 2027
Our predictive algorithms indicate Compass Therapeutics, Inc. stock may see a shift in April 2027. The expected range spans $0.65–$3.90, with an average target of $3.24. This represents a positive outlook and a possible gain of +69.63%.
May 2027
Analyzing established trends, Compass Therapeutics, Inc. looks set to move in May 2027. Projections place the stock between $0.09 and $1.72, averaging around $1.54. This suggests a -19.37% loss from current levels.
June 2027
Market indicators suggest Compass Therapeutics, Inc. could experience notable changes during June 2027. Prices could fluctuate within $0.00 to $1.25, with a midpoint forecast of $1.47. The stock might deliver a -23.04% loss.
July 2027
Forecasting for July 2027, models estimate that Compass Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.02, averaging $1.39. This signals a cautious trajectory with potential returns around -27.23%.
CMPX's history of dividends and stock splits also plays a role in long-term investor confidence.

